A survey of physician experience and treatment satisfaction prescribing once-weekly semaglutide injections for patients with type 2 diabetes in Canada

Cardiovascular Endocrinology & Metabolism · Published 2022-03-23 · DOI 10.1097/xce.0000000000000260

Authors being retrieved — see the publisher record. https://doi.org/10.1097/xce.0000000000000260

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2022

Related articles